The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2005
DOI: 10.46850/elni.2005.015
|View full text |Cite
|
Sign up to set email alerts
|

Rethinking the Role of Information in Chemicals Policy: Implications for TSCA and REACH

Abstract: This article analyzes the role of different kinds of information for minimizing or eliminating the risks due to the production, use, and disposal of chemical substances and contrasts it with present and planned (informational) regulation in the United States and the European Union, respectively. Some commentators who are disillusioned with regulatory approaches have argued that informational tools should supplant mandatory regulatory measures unflatteringly described as “command and control.” Critics of this r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2018
2018

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 17 publications
0
1
0
Order By: Relevance
“…It makes heavy use of non‐standard scientific methodologies, particularly SARs . There is still controversial debate on how to use this evidence in decision‐making so as to process a huge number of untested compounds: analyzing each one individually—which is the default strategy under REACH—or regulating an entire category of substances based on “innate” properties such as bioaccumulation or environmental persistence without detailed data on each substance . This example shows a regulatory controversy that is typical for risk assessment, and directly relates to the type and level of admissible evidence for decision‐making.…”
Section: Regulatory Dilemmas and Methodological Controversiesmentioning
confidence: 99%
“…It makes heavy use of non‐standard scientific methodologies, particularly SARs . There is still controversial debate on how to use this evidence in decision‐making so as to process a huge number of untested compounds: analyzing each one individually—which is the default strategy under REACH—or regulating an entire category of substances based on “innate” properties such as bioaccumulation or environmental persistence without detailed data on each substance . This example shows a regulatory controversy that is typical for risk assessment, and directly relates to the type and level of admissible evidence for decision‐making.…”
Section: Regulatory Dilemmas and Methodological Controversiesmentioning
confidence: 99%